Planetary health may not be what immediately comes to mind when you think of Aspirin, but they’re more connected than you might realize.
Bayer AG has initiated several “100 million challenges,” including its recent investment in sustainable health products to advance the company’s 2030 sustainability commitments. They’re pouring €100 million to further enable sustainable innovation, production, and consumption of Consumer Health products including global brands such as Aspirin, Bepanthen, Claritin, and Elevit.
We’ll get to the packaging details shortly. But first, it’s important to see the connection between human health and the environment. “When you think about the environment and climate issues, we're talking about the environment as a social determinant of health,” says Daniella Foster, Global Vice President and Head of Public Affairs, Science, and Sustainability for Bayer’s Consumer Health division. “Reflecting on the past 20 years, we know that climate change has been a cause behind a growing number of health concerns, and we also know that underserved populations are particularly vulnerable.”